Cargando…

Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes

AIMS/HYPOTHESIS: Oxidation of LDL in the arterial extracellular matrix is a key event in the development of atherosclerosis and autoantibodies against oxidised LDL antigens reflect disease severity and the risk of developing acute cardiovascular events. Since type 2 diabetes is associated with incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fredrikson, G. N., Anand, D. V., Hopkins, D., Corder, R., Alm, R., Bengtsson, E., Shah, P. K., Lahiri, A., Nilsson, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688611/ https://www.ncbi.nlm.nih.gov/pubmed/19448981 http://dx.doi.org/10.1007/s00125-009-1377-9

Ejemplares similares

Circulating Autoantibodies against the Apolipoprotein B-100 Peptides p45 and p210 in Relation to the Occurrence of Carotid Plaques in 64-Year-Old Women
por: Fagerberg, Björn, et al.
Publicado: (2015)

Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
por: Sveen, Kari Anne, et al.
Publicado: (2021)

IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice
por: Mantani, Polyxeni T., et al.
Publicado: (2015)

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE(-/-) mice
por: Dunér, Pontus, et al.
Publicado: (2021)

Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
por: L’Huillier, Arnaud G., et al.
Publicado: (2022)

Autoantibodies against basement membrane collagen type IV are associated with myocardial infarction
por: McLeod, Olga, et al.
Publicado: (2014)

Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives
por: Teixeira, P. C., et al.
Publicado: (2012)

ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
por: Mantani, Polyxeni T., et al.
Publicado: (2019)

Antibodies Against Gonadotropin-Releasing Hormone in Patients with Posterior Laryngitis
por: Pendleton, Hillevi, et al.
Publicado: (2013)

An apolipoprotein B100 mimotope prevents obesity in mice
por: Kim, Hyo Joon, et al.
Publicado: (2015)

Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque
por: Egusa, Genshi
Publicado: (2021)

Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
por: Bridge, Simon H., et al.
Publicado: (2018)

Apolipoprotein E mimetic peptide protects against diffuse brain injury
por: Zhao, Yaning, et al.
Publicado: (2014)

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
por: Wolkowicz, Paul, et al.
Publicado: (2021)

CFTR protects against vascular inflammation and atherogenesis in apolipoprotein E-deficient mice
por: Li, Zhengzhang, et al.
Publicado: (2017)

Medial Expression of TNF-α and TNF Receptors Precedes the Development of Atherosclerotic Lesions in Apolipoprotein E/LDL Receptor Double Knockout Mice
por: Niemann-Jönsson, Audrey, et al.
Publicado: (2007)

The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
por: Di Bartolo, Belinda A, et al.
Publicado: (2011)

Structural changes induced by acidic pH in human apolipoprotein B-100
por: Fernández-Higuero, José A., et al.
Publicado: (2016)

Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients
por: Anderson, Josephine L.C., et al.
Publicado: (2019)

Effect of urotensin II on apolipoprotein B(100) and apolipoprotein A-I expression in HepG2 cell line
por: Mohammadi, Abbas, et al.
Publicado: (2014)

Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence
por: Wang, Meili, et al.
Publicado: (2019)

Apolipoprotein M
por: Luo, Guanghua, et al.
Publicado: (2004)

Inhibition of Vascular Inflammation by Apolipoprotein A-IV
por: Shearston, Kate, et al.
Publicado: (2022)

Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014)

High throughput quantification of apolipoproteins A‐I and B‐100 by isotope dilution MS targeting fast trypsin releasable peptides without reduction and alkylation
por: Parks, Bryan A, et al.
Publicado: (2017)

The N-terminal domain of apolipoprotein B-100: structural characterization by homology modeling
por: Al-Ali, Hassan, et al.
Publicado: (2007)

Identification of Two Regions in Apolipoprotein B100 that are Exposed on the Cytosolic Side of the Endoplasmic Reticulum Membrane
por: Du, Xiaobo, et al.
Publicado: (1998)

Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy
por: Berntorp, Kerstin, et al.
Publicado: (2013)

Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
por: Sjöwall, Christopher, et al.
Publicado: (2004)

Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides
por: Hansson, Monika, et al.
Publicado: (2012)

Autoantibodies against appetite-regulating peptide hormones and neuropeptides: Putative modulation by gut microflora
por: Fetissov, Sergueï O., et al.
Publicado: (2008)

Autoantibody Responses to Apolipoprotein A-I Are Not Diet- or Sex-Linked in C57BL/6 Mice
por: Pitts, Michelle G., et al.
Publicado: (2020)

Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse
por: Vasquez, Elisardo C, et al.
Publicado: (2012)

Therapeutic expression of hairpins targeting apolipoprotein B100 induces phenotypic and transcriptome changes in murine liver
por: Maczuga, P, et al.
Publicado: (2014)

Associations Between Macrophage Colony‐Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First‐Time Coronary Events: A Nested Case–Control Study
por: Schiopu, Alexandru, et al.
Publicado: (2016)

Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells
por: Yanagita, Teruyoshi, et al.
Publicado: (2008)

Detection of circulating IgG antibodies to apolipoprotein B(100) in acute myocardial infarction
por: Zhang, Xueying, et al.
Publicado: (2015)

Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C
por: Schaefer, Esperance A K, et al.
Publicado: (2016)

Sortilin restricts secretion of apolipoprotein B-100 by hepatocytes under stressed but not basal conditions
por: Conlon, Donna M., et al.
Publicado: (2022)

Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis
por: Wong, Jamie K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a2c12ciiuoqs5nsb15r2tfgsd1